Evaluation of Prucalopride in Subjects With Moderate and Severe Hepatic Impairment
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This is a single centre, open-label phase I trial to investigate the effects of moderate to
severe hepatic impairment on the pharmacokinetics of prucalopride in comparison with healthy
volunteers. Furthermore the short-term safety and tolerability of a single dose of
prucalopride will be assessed.